As of November 2024, Gongwin Biopharm Holdings has a market cap of $427.01M. This makes Gongwin Biopharm Holdings the world's 12381th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $682.15M | 7.24% |
2023 | $636.09M | -42.38% |
2022 | $1.10B | 11.05% |
2021 | $993.99M | 16.39% |
2020 | $854.02M | 201.29% |
2019 | $283.46M | 19.75% |
2018 | $236.72M | 3.92% |
2017 | $227.79M | - |